Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
ClinicoEconomics and Outcomes Research · 2024-10 · Volume 16 · 761-769
DOI: 10.2147/ceor.s489783 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2024-10. Verfasst von Chien-Yu Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung Uni…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Szu-Chun Yang
Zitieren
APA
Lin, C. Y., Wu, T. I., & Yang, S. C. (2024). Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer. ClinicoEconomics and Outcomes Research, Volume 16, 761-769. https://doi.org/10.2147/ceor.s489783
Vancouver
Lin CY, Wu TI, Yang SC. Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer. ClinicoEconomics and Outcomes Research. 2024;Volume 16:761-769. doi:10.2147/ceor.s489783
BibTeX
@article{Lin2024,
author = {Lin, Chien-Yu and Wu, Tzu-I and Yang, Szu-Chun},
title = {Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer},
journal = {ClinicoEconomics and Outcomes Research},
year = {2024},
volume = {Volume 16},
pages = {761--769},
doi = {10.2147/ceor.s489783}
}
EUVIMED